Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 188 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/15/15
End: 07/30/17
Due: 07/30/18
Phase: N/A
Priority: Normal
Start: 04/01/20
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 08/31/08
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 09/01/23
Due: 09/01/24
Phase: N/A
Priority: Normal
Start: 08/06/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 07/25/22
End: 01/29/23
Due: 01/29/24
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 04/01/20
End: 08/01/20
Due: 08/01/21
Phase: N/A
Priority: Normal
Start: 05/03/21
End: 03/03/23
Due: 03/03/24
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 04/30/18
Due: 04/30/19
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 06/30/18
Due: 06/30/19
Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 03/01/18
Due: 03/01/19
Phase: N/A
Priority: Normal
Start: 07/04/18
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 11/01/23
Due: 11/01/24
Phase: N/A
Priority: Normal
Start: 07/03/20
End: 04/18/21
Due: 04/18/22
Phase: N/A
Priority: Normal
Start: 09/12/18
End: 11/19/18
Due: 11/19/19
Phase: N/A
Priority: Normal
Start: 05/30/21
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 12/31/17
Due: 12/31/18